MedTrace Logo

Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms

NCT00460538 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2010-04-05

No results posted yet for this study

Summary

The purpose of the study is to determine weather Lectranal is effective in treatment of seasonal allergic rhinitis symptoms.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

DIETARY_SUPPLEMENT

Lectranal

Dosage form: capsule 1: Dosage: 2 capsule Frequency and duration: 2 times daily over the 6 weeks

DIETARY_SUPPLEMENT

placebo

Dosage form: capsule 2: Dosage: 2 capsules Frequency and duration: 2 times daily over the 6 weeks

Sponsors & Collaborators

  • Milsing d.o.o.

    lead OTHER

Principal Investigators

  • Neven Tudoric, MD PhD · Dubrava University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2007-10-31
Completion
2007-11-30

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00460538 on ClinicalTrials.gov